Circulating miRNAs as a Tool for Early Diagnosis of Endometrial Cancer—Implications for the Fertility-Sparing Process: Clinical, Biological, and Legal Aspects

This review article explores the possibility of developing an integrated approach to the management of the different needs of endometrial cancer (EC) patients seeking to become pregnant. Life preservation of the woman, health preservation of the baby, a precocious and—as much as possible—minimally invasive characterization of the health and fertility parameters of the patient, together with the concerns regarding the obstetric, neonatal, and adult health risks of the children conceived via assisted reproductive techniques (ART) are all essential aspects of the problem to be taken into consideration, yet the possibility to harmonize such needs through a concerted and integrated approach is still very challenging. This review aims to illustrate the main features of EC and how it affects the normal physiology of pre-menopausal women. We also focus on the prospect of a miR-based, molecular evaluation of patient health status, including both EC early diagnosis and staging and, similarly, the receptivity of the woman, discussing the possible evaluation of both aspects using a single specific panel of circulating miRs in the patient, thus allowing a relatively fast, non-invasive testing with a significantly reduced margin of error. Finally, the ethical and legal/regulatory aspects of such innovative techniques require not only a risk-benefit analysis; respect for patient autonomy and equitable health care access allocation are fundamental issues as well.

[1]  Jibiao Wu,et al.  ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  S. Garzon,et al.  Fertility-Sparing Strategies for Early-Stage Endometrial Cancer: Stepping towards Precision Medicine Based on the Molecular Fingerprint , 2023, International journal of molecular sciences.

[3]  A. Di Spiezio Sardo,et al.  ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. , 2023, Facts, views & vision in ObGyn.

[4]  G. Cucinella,et al.  COVID-19 and female fertility: the flaws of Italian Law 40/2004 on assisted procreation in pandemic times , 2022, Acta bio-medica : Atenei Parmensis.

[5]  P. Patrizio,et al.  Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes , 2022, Cancers.

[6]  G. Bifulco,et al.  Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review , 2022, BioMed research international.

[7]  A. Samadani,et al.  Survival-based bioinformatics analysis to identify hub long non-coding RNAs along with lncRNA-miRNA-mRNA network for potential diagnosis/prognosis of thyroid cancer , 2022, Journal of Cell Communication and Signaling.

[8]  M. Scaglione,et al.  Neonatal Outcomes and Long-Term Follow-Up of Children Born from Frozen Embryo, a Narrative Review of Latest Research Findings , 2022, Medicina.

[9]  M. Stark,et al.  Fertility Preservation in Oncological Patients , 2022, Clinical and Experimental Obstetrics & Gynecology.

[10]  R. Piergentili,et al.  Using ncRNAs as Tools in Cancer Diagnosis and Treatment—The Way towards Personalized Medicine to Improve Patients’ Health , 2022, International journal of molecular sciences.

[11]  Jing-mei Su,et al.  lncRNA NBAT1 Inhibits Cell Metastasis and Promotes Apoptosis in Endometrial Cancer by Sponging miR-21-5p to Regulate PTEN , 2022, Computational and mathematical methods in medicine.

[12]  P. Chu,et al.  Construction of Endometrial Carcinoma ceRNA Network and Screening of Key Genes Based on TCGA Database , 2022, Computational and mathematical methods in medicine.

[13]  C. Uzan,et al.  Clinical Value and Molecular Function of Circulating MicroRNAs in Endometrial Cancer Regulation: A Systematic Review , 2022, Cells.

[14]  G. Nie,et al.  MicroRNAs in the Regulation of Endometrial Receptivity for Embryo Implantation , 2022, International journal of molecular sciences.

[15]  E. Crosbie,et al.  Current and Emerging Prognostic Biomarkers in Endometrial Cancer , 2022, Frontiers in Oncology.

[16]  F. Signore,et al.  Fertility preservation in female cancer sufferers: (only) a moral obligation? , 2022, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[17]  S. M. Jafarnejad,et al.  The intricate balance between microRNA‐induced mRNA decay and translational repression , 2022, The FEBS journal.

[18]  G. Gullo,et al.  Biomolecular and Genetic Prognostic Factors That Can Facilitate Fertility-Sparing Treatment (FST) Decision Making in Early Stage Endometrial Cancer (ES-EC): A Systematic Review , 2022, International journal of molecular sciences.

[19]  R. Tsutsumi,et al.  LncRNA–miRNA–mRNA regulatory axes in endometrial cancer: a comprehensive overview , 2022, Archives of Gynecology and Obstetrics.

[20]  Cross-border reproductive care: an Ethics Committee opinion. , 2022, Fertility and sterility.

[21]  G. Cucinella,et al.  Open vs. closed vitrification system: which one is safer? , 2022, European review for medical and pharmacological sciences.

[22]  Xiao Feng,et al.  Long non-coding RNA NNT-AS1 positively regulates NPM1 expression to affect the proliferation of estrogen-mediated endometrial carcinoma by interacting , 2022, Journal of Cancer.

[23]  N. Potenza,et al.  The lncRNAs at X Chromosome Inactivation Center: Not Just a Matter of Sex Dosage Compensation , 2022, International journal of molecular sciences.

[24]  M. Terzic,et al.  Contemporary Fertility-Sparing Management Options of Early Stage Endometrioid Endometrial Cancer in Young Nulliparous Patients , 2021, Journal of clinical medicine.

[25]  D. Levine,et al.  Endometrial cancer , 2021, Nature Reviews Disease Primers.

[26]  Yushui Ma,et al.  The role of ceRNA-mediated diagnosis and therapy in hepatocellular carcinoma , 2021, Hereditas.

[27]  P. Hrelia,et al.  Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review , 2021, International journal of cancer.

[28]  Y. Terada,et al.  MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas , 2021, Journal of gynecologic oncology.

[29]  G. Scambia,et al.  Towards Personalized Medicine: Non-Coding RNAs and Endometrial Cancer , 2021, Healthcare.

[30]  P. Włodarski,et al.  The Role of miRNAs in the Regulation of Endometrial Cancer Invasiveness and Metastasis—A Systematic Review , 2021, Cancers.

[31]  Wei Zhu,et al.  MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer , 2021, Bioscience reports.

[32]  O. Chabre,et al.  MicroRNA Therapeutics in Cancer: Current Advances and Challenges , 2021, Cancers.

[33]  H. Cui,et al.  Competing Endogenous RNA Networks in Glioma , 2021, Frontiers in Genetics.

[34]  Huo Zhang,et al.  Three plasma-based microRNAs as potent diagnostic biomarkers for endometrial cancer. , 2021, Cancer biomarkers : section A of Disease markers.

[35]  C. Faravelli,et al.  Assessing psychological needs in female cancer patients: a tailored model , 2021, Acta bio-medica : Atenei Parmensis.

[36]  F. Gorlero,et al.  New Insights into Endometrial Cancer , 2021, Cancers.

[37]  Qun Wang,et al.  Insight Into the Prospects for RNAi Therapy of Cancer , 2021, Frontiers in Pharmacology.

[38]  G. Scambia,et al.  Non-Coding RNAs as Prognostic Markers for Endometrial Cancer , 2021, International journal of molecular sciences.

[39]  R. Ghazala,et al.  Circulating miRNA 27a and miRNA150-5p; a noninvasive approach to endometrial carcinoma , 2021, Molecular Biology Reports.

[40]  J. Knez,et al.  The Perspectives of Fertility Preservation in Women with Endometrial Cancer , 2021, Cancers.

[41]  A. Pasanen,et al.  Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer , 2021, Cancer medicine.

[42]  Yiran Cai,et al.  Comprehensive bioinformatic analyses of lncRNA-mediated ceRNA network for uterine corpus endometrial carcinoma , 2021, Translational cancer research.

[43]  S. Cantara,et al.  miRNA Targets: From Prediction Tools to Experimental Validation , 2020, Methods and protocols.

[44]  Cyrus Chargari,et al.  ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma , 2020, International Journal of Gynecological Cancer.

[45]  J. Toivonen,et al.  Competing Endogenous RNA Networks as Biomarkers in Neurodegenerative Diseases , 2020, International journal of molecular sciences.

[46]  E. Montagna,et al.  Endometrial cancer: a genetic point of view , 2020, Translational cancer research.

[47]  P. Rameshwar,et al.  Non-Coding RNAs as Mediators of Epigenetic Changes in Malignancies , 2020, Cancers.

[48]  F. Amant,et al.  ESHRE guideline: female fertility preservation† , 2020, Human reproduction open.

[49]  A. Krętowski,et al.  Insulin Resistance and Endometrial Cancer: Emerging Role for microRNA , 2020, Cancers.

[50]  S. Brouillet,et al.  Endometrial miRNome profile according to the receptivity status and implantation failure , 2020, Human fertility.

[51]  K. Hua,et al.  LncRNA RP11-395G23.3 suppresses the endometrial cancer progression via regulating microRNA-205-5p/PTEN axis. , 2020, American journal of translational research.

[52]  Zi-jiang Chen,et al.  MiR-148a-3p may contribute to flawed decidualization in recurrent implantation failure by modulating HOXC8 , 2020, Journal of Assisted Reproduction and Genetics.

[53]  J. McAlpine,et al.  Fertility-sparing treatment in early endometrial cancer: current state and future strategies , 2020, Obstetrics & gynecology science.

[54]  B. Wiweko,et al.  Suppressing HOXA-10 Gene Expression by MicroRNA 135b During the Window of Implantation in Infertile Women , 2020, Journal of reproduction & infertility.

[55]  G. Lippi,et al.  Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer , 2020, Pathology & Oncology Research.

[56]  R. Bekkers,et al.  Diagnostic value of microRNA panel in endometrial cancer: A systematic review , 2020, Oncotarget.

[57]  Z. Zong,et al.  CircRNA WHSC1 targets the miR‐646/NPM1 pathway to promote the development of endometrial cancer , 2020, Journal of cellular and molecular medicine.

[58]  K. Hua,et al.  lncRNA LA16c‑313D11.11 modulates the development of endometrial cancer by binding to and inhibiting microRNA‑205‑5p function and indirectly increasing PTEN activity. , 2020, International journal of oncology.

[59]  M. Koskas,et al.  Lymph node metastasis probability in young patients eligible for conservative management of endometrial cancer. , 2020, Gynecologic oncology.

[60]  Yan Yao,et al.  Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network , 2020, Journal of cellular biochemistry.

[61]  A. Lophatananon,et al.  Association between genetic polymorphisms and endometrial cancer risk: a systematic review , 2020, Journal of Medical Genetics.

[62]  Xinting Sang,et al.  CeRNA regulatory network-based analysis to study the roles of noncoding RNAs in the pathogenesis of intrahepatic cholangiocellular carcinoma , 2020, Aging.

[63]  W. Yeung,et al.  Mir-let-7a/g Enhances Uterine Receptivity via Suppressing Wnt/β-Catenin Under the Modulation of Ovarian Hormones , 2020, Reproductive Sciences.

[64]  M. Guida,et al.  TCGA molecular groups of endometrial cancer: Pooled data about prognosis. , 2019, Gynecologic oncology.

[65]  Lin Xu,et al.  The TWIST1-centered competing endogenous RNA network promotes proliferation, invasion, and migration of lung adenocarcinoma , 2019, Oncogenesis.

[66]  M. Liguori,et al.  The MicroRNA Centrism in the Orchestration of Neuroinflammation in Neurodegenerative Diseases , 2019, Cells.

[67]  R. Cippitani Ethical issues and law-making power: how European case law has rewritten Italian law on medically assisted reproduction , 2019, Monash bioethics review.

[68]  Ji-Ho Park,et al.  Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery , 2019, Advanced materials.

[69]  C. Uzan,et al.  The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis , 2019, Cancers.

[70]  Ryan L Setten,et al.  The current state and future directions of RNAi-based therapeutics , 2019, Nature Reviews Drug Discovery.

[71]  Yang Liu,et al.  miR-21 reverses impaired decidualization through modulation of KLF12 and NR4A1 expression in human endometrial stromal cells†. , 2019, Biology of reproduction.

[72]  P. Yu,et al.  Long noncoding RNA GAS5 impairs the proliferation and invasion of endometrial carcinoma induced by high glucose via targeting miR-222-3p/p27. , 2019, American journal of translational research.

[73]  C. Gilks,et al.  Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists , 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[74]  M. Amoli,et al.  Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer , 2018, Journal of cellular physiology.

[75]  Jia-xin Yang,et al.  Fertility-preserving treatment in women with early endometrial cancer: the Chinese experience , 2018, Cancer management and research.

[76]  C. Peng,et al.  Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..

[77]  Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. , 2018, Fertility and sterility.

[78]  Lin Sang,et al.  Long noncoding RNA LINC00261 regulates endometrial carcinoma progression by modulating miRNA/FOXO1 expression , 2018, Cell biochemistry and function.

[79]  Wei Huang,et al.  miR-194-3p Represses the Progesterone Receptor and Decidualization in Eutopic Endometrium From Women With Endometriosis , 2018, Endocrinology.

[80]  Jie Shen,et al.  Long noncoding RNA HOTAIR mediates the estrogen-induced metastasis of endometrial cancer cells via the miR-646/NPM1 axis. , 2018, American journal of physiology. Cell physiology.

[81]  Yvonne Tay,et al.  Noncoding RNA:RNA Regulatory Networks in Cancer , 2018, International journal of molecular sciences.

[82]  K. Oktay,et al.  Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  Rakhi Ghoshal Assisted reproductive technologies: Conundrums and challenges. , 2018, Indian journal of medical ethics.

[84]  L. Putignani,et al.  Non-Coding RNAs and Endometrial Cancer , 2018, Genes.

[85]  R. Ke,et al.  Ethical considerations in the field of assisted reproductive technology. , 2018, Minerva endocrinologica.

[86]  N. S. Lima Narrative Identity in Third Party Reproduction: Normative Aspects and Ethical Challenges , 2018, Journal of Bioethical Inquiry.

[87]  Mu Xu,et al.  A six-microRNA signature predicts survival of patients with uterine corpus endometrial carcinoma. , 2018, Current problems in cancer.

[88]  S. Modesitt,et al.  Current and future role of genetic screening in gynecologic malignancies , 2017, American journal of obstetrics and gynecology.

[89]  J. Cui,et al.  Dynamic and Modularized MicroRNA Regulation and Its Implication in Human Cancers , 2017, Scientific Reports.

[90]  G. Lippi,et al.  Evaluation of mir-203 Expression Levels and DNA Promoter Methylation Status in Serum of Patients with Endometrial Cancer. , 2017, Clinical laboratory.

[91]  F. Martínez Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. , 2017, Fertility and sterility.

[92]  Weiyuan Zhang,et al.  Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia , 2017, Medicine.

[93]  A. Graham,et al.  miR-181b-5p Modulates Cell Migratory Proteins, Tissue Inhibitor of Metalloproteinase 3, and Annexin A2 During In Vitro Decidualization in a Human Endometrial Stromal Cell Line , 2017, Reproductive Sciences.

[94]  Priit Adler,et al.  Meta-signature of human endometrial receptivity: a meta-analysis and validation study of transcriptomic biomarkers , 2017, Scientific Reports.

[95]  G. Rücker,et al.  Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro. , 2017, Oncology reports.

[96]  K. Schoch,et al.  Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases , 2017, Neuron.

[97]  Cheng Shi,et al.  Endometrial MicroRNA Signature during the Window of Implantation Changed in Patients with Repeated Implantation Failure , 2017, Chinese medical journal.

[98]  Wang He,et al.  Diagnostic value of circulating miR-21: An update meta-analysis in various cancers and validation in endometrial cancer , 2016, Oncotarget.

[99]  C. Mendelson,et al.  miR-200 Regulates Endometrial Development During Early Pregnancy. , 2016, Molecular endocrinology.

[100]  V. Granata,et al.  Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer , 2016, Journal of gynecologic oncology.

[101]  Jia-xin Yang,et al.  Oral Progestin Treatment for Early-Stage Endometrial Cancer: A Systematic Review and Meta-analysis , 2016, International Journal of Gynecologic Cancer.

[102]  L. Mileshkin,et al.  PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer. , 2016, The Cochrane database of systematic reviews.

[103]  K. Klinga-Levan,et al.  Verification of microRNA expression in human endometrial adenocarcinoma , 2016, BMC Cancer.

[104]  J. Carpten,et al.  Translating RNA sequencing into clinical diagnostics: opportunities and challenges , 2016, Nature Reviews Genetics.

[105]  E. Darai,et al.  Endometrial cancer , 2016, The Lancet.

[106]  J. Ledermann,et al.  ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer , 2015, International Journal of Gynecologic Cancer.

[107]  R. Scott RISKS, REASONS AND RIGHTS: THE EUROPEAN CONVENTION ON HUMAN RIGHTS AND ENGLISH ABORTION LAW , 2015, Medical law review.

[108]  H. Dai,et al.  LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells , 2015, Journal of Biomedical Science.

[109]  J. D. Watson,et al.  Human Genome Project: Twenty-five years of big biology , 2015, Nature.

[110]  A. Talhouk,et al.  A clinically applicable molecular-based classification for endometrial cancers , 2015, British Journal of Cancer.

[111]  F. Gong,et al.  Inhibition of Endometrial Tiam1/Rac1 Signals Induced by miR-22 Up-Regulation Leads to the Failure of Embryo Implantation During the Implantation Window in Pregnant Mice1 , 2015, Biology of reproduction.

[112]  J. Gregg,et al.  Optimal Molecular Methods in Detecting p190BCR-ABL Fusion Variants in Hematologic Malignancies: A Case Report and Review of the Literature , 2015, Case reports in hematology.

[113]  Yue Jiang,et al.  MicroRNA-181a is involved in the regulation of human endometrial stromal cell decidualization by inhibiting Krüppel-like factor 12 , 2015, Reproductive Biology and Endocrinology.

[114]  K. Yoneyama,et al.  miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma. , 2015, Anticancer research.

[115]  M. Sadeghizadeh,et al.  Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids , 2014, Medical Oncology.

[116]  X. Shen,et al.  Circulating microRNAs as a Fingerprint for Endometrial Endometrioid Adenocarcinoma , 2014, PloS one.

[117]  Q. Jiang,et al.  Integrated microRNA and mRNA Transcriptome Sequencing Reveals the Potential Roles of miRNAs in Stage I Endometrioid Endometrial Carcinoma , 2014, PloS one.

[118]  Eric Blyth,et al.  Assisted reproductive technology in the USA: Is more regulation needed? , 2014, Reproductive biomedicine online.

[119]  S. Martínez,et al.  The transcriptomic and proteomic effects of ectopic overexpression of miR-30d in human endometrial epithelial cells. , 2014, Molecular human reproduction.

[120]  S. Dey,et al.  MicroRNA-200a locally attenuates progesterone signaling in the cervix, preventing embryo implantation. , 2014, Molecular endocrinology.

[121]  A. Andreano,et al.  MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis , 2014, European Radiology.

[122]  M. Kaneuchi,et al.  Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma. , 2014, Gynecologic oncology.

[123]  P. Morris From Mendel to the Human Genome Project. , 2013, North Carolina medical journal.

[124]  Pier Paolo Pandolfi,et al.  ceRNA cross-talk in cancer: when ce-bling rivalries go awry. , 2013, Cancer discovery.

[125]  R. Lobo,et al.  Cancer risk and PCOS , 2013, Steroids.

[126]  M. Pike,et al.  Type I and II endometrial cancers: have they different risk factors? , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[127]  K. Oktay,et al.  Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[128]  Chenyu Zhang,et al.  Identification of four serum microRNAs from a genome-wide serum microRNA expression profile as potential non-invasive biomarkers for endometrioid endometrial cancer , 2013, Oncology letters.

[129]  Steven J. M. Jones,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[130]  G. Zamboni,et al.  Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients , 2013, International journal of cancer.

[131]  A. Stavreus-Evers,et al.  MicroRNAs miR-30b, miR-30d, and miR-494 Regulate Human Endometrial Receptivity , 2013, Reproductive Sciences.

[132]  Mana Moghadamfalahi,et al.  The Significance of Lower Uterine Segment Involvement in the Surgical Management of Endometrial Carcinoma , 2012 .

[133]  A. Coomarasamy,et al.  Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. , 2012, American journal of obstetrics and gynecology.

[134]  G. Zamboni,et al.  Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma , 2012, BMC Cancer.

[135]  C. Kang,et al.  Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma , 2012, Modern Pathology.

[136]  K. Shroyer,et al.  Prognostic Significance of miR-205 in Endometrial Cancer , 2012, Biomarker Research.

[137]  V. Gebski,et al.  Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature. , 2012, Gynecologic oncology.

[138]  E. Sala,et al.  Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2012, Radiology.

[139]  Sven Laur,et al.  Robust rank aggregation for gene list integration and meta-analysis , 2012, Bioinform..

[140]  M. Goodheart,et al.  microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs. , 2011, Oncology reports.

[141]  R. Reich,et al.  MicroRNAs are associated with human embryo implantation defects. , 2011, Human reproduction.

[142]  J. Schenker Ethical Dilemmas in Assisted Reproductive Technologies , 2011 .

[143]  H. Feilotter,et al.  The MicroRNA-200 Family Is Upregulated in Endometrial Carcinoma , 2011, PloS one.

[144]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[145]  J. Weidhaas,et al.  MicroRNA signatures differentiate uterine cancer tumor subtypes. , 2010, Gynecologic oncology.

[146]  Muller Fabbri,et al.  Comprehensive miRNA profiling of surgically staged endometrial cancer. , 2010, American journal of obstetrics and gynecology.

[147]  Takashi Suzuki,et al.  Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas , 2010, Cancer science.

[148]  S. Mok,et al.  Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women , 2009, International journal of cancer.

[149]  Zhongqiu Lin,et al.  Expression profile of mammalian microRNAs in endometrioid adenocarcinoma , 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[150]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[151]  H. Dressman,et al.  MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. , 2008, Gynecologic oncology.

[152]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[153]  F. Pedersen,et al.  Ethical Perspectives on RNA Interference Therapeutics , 2008, International journal of medical sciences.

[154]  J. Robertson Cancer and fertility: ethical and legal challenges. , 2005, Journal of the National Cancer Institute. Monographs.

[155]  P. Maisonneuve,et al.  Carcinoma of the corpus uteri , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[156]  C. Eng,et al.  Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. , 2000, Journal of the National Cancer Institute.

[157]  C. Mello,et al.  Wnt Signaling and an APC-Related Gene Specify Endoderm in Early C. elegans Embryos , 1997, Cell.

[158]  T. Friedmann A brief history of gene therapy , 1992, Nature Genetics.

[159]  G. J. Dimitriadis Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes , 1978, Nature.

[160]  R. Symons,et al.  Biochemical method for inserting new genetic information into DNA of Simian Virus 40: circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[161]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[162]  G. Pennings,et al.  Extraterritorial laws for cross-border reproductive care: the issue of legal diversity. , 2012, European journal of health law.

[163]  D. Roberts,et al.  Medical hope, legal pitfalls: potential legal issues in the emerging field of oncofertility. , 2010, Cancer treatment and research.

[164]  L. Zoloth,et al.  Oncofertility: ethical, legal, social, and medical perspectives. Preface. , 2010, Cancer treatment and research.

[165]  Patrick Neven,et al.  Endometrial cancer. , 2005, Lancet.

[166]  F. Grad The Preamble of the Constitution of the World Health Organization. , 2002, Bulletin of the World Health Organization.

[167]  M. Sherman,et al.  Endometrial cancer chemoprevention: Implications of diverse pathways of carcinogenesis , 1995, Journal of cellular biochemistry. Supplement.

[168]  A. Riggs,et al.  Expression in Escherichia coli of chemically synthesized genes for human insulin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.